- 2.9Impact Factor
- 5.2CiteScore
- 18 daysTime to First Decision
New Insights into Breast Neoplasms: Prevention, Multidisciplinary Management and Beyond the Core Team
This special issue belongs to the section “Oncology“.
Special Issue Information
Dear Colleagues,
Breast cancer is the most frequently diagnosed malignancy worldwide, and its incidence is expected to further increase in the coming decades as a consequence of population aging and modifiable risk factors. While transitioned countries are projected to face the greatest cancer burden, innovation in multidisciplinary care is urgently needed to reduce morbidity, optimize healthcare resources, and ensure equitable access to high-quality treatment.
This Special Issue of the Journal of Clinical Medicine aims to explore recent advances in breast cancer management, with particular attention to both oncological outcomes and patient-reported outcome measures. Beyond the traditional domains of diagnosis and treatment, the initiative seeks to embrace contributions from a broad range of specialties, including clinical genetics, rehabilitation, psycho-oncology, and supportive care, in order to provide a truly comprehensive vision of breast cancer care. By addressing consolidated practices as well as unmet clinical and patient-centered needs, this collection aspires to underline the importance of an integrated approach that not only treats the disease but also cares for the individual. Through this holistic perspective, the Special Issue emphasizes the role of innovation in bridging equity gaps, improving quality of life, and advancing the global standards of breast cancer care.
Dr. Marco Materazzo
Dr. Antonia Girardi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- tumor heterogeneity
- estrogen receptor
- progesterone receptor
- triple-negative breast cancer
- metastasis
- immunotherapy
- targeted therapy
- early detection
- prognosis
- adjuvant treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

